Follow Us:Respiratio 2023, 13, (1-2): 63-69
IZAZOVI LEČENJA U RESPIRATORNOJ JEDINICI INTENZIVNE NEGE U POSTKOVID PERIODU
CHALLENGES OF TREATMENT IN THE RESPIRATORY INTENSIVE CARE UNIT IN THE POSTCOVID PERIOD
Stefan Šajnović1, Marija Marinković1, 
Marija Topalović1, Kristina Jović1, Marko
Bjelaković1, Borislav Božanić1, Bojan Ljubenović1, Nikola Rančev1
Original Research
Naučni članak
Uvod: Respiratorne JIL predstavljale su koristan resors za zbrinjavanje kompleksnih, veoma teških oblika COVID-19. U trenutku kada COVID-19 pandemija polako jenjava, ove jedinice postepeno vraćaju svoju osnovnu funkciju zbrinjavanja teških formi hroničnih i akutnih plućnih bolesti. Cilj istraživanja bio je prikazati profil pacijenata, izazove u lečenju i rezultate rada odeljenja intenzivne nege Klinike za pulmologiju UKC Niš u periodu nakon vanredne situacije izazvane COVID-19 pandemijom.
Metode: Retrospektivna studija obuhvatila je 213 pacijenata lečenih na odeljenju intenzivne naše klinike u periodu od 9 meseci. Rezultati su dobijeni analizom podataka iz istorije bolesti pacijenata i dostupne medicinske dokumentacije. Dokumentovani parametri koji su ovom studijom obuhvaćeni bili su demografske i socijalno-epidemiološke karakteristike ispitanika, prisustvo štetnih navika, komorbiditeti, osnovni uzrok hospitalizacije, terapijski pristup i ishod lečenja.
Rezultati: Nije bilo statistički značajne razlike u godinama između polova (t=0.773, p=0.440). Analizom odnosa između učestalosti HOBP i pola, nije dokazana statistički značajna razlika (Χ=0.173, p=0.678). Ne postoji statistički značajna razlika između broja bolničkih dana i ishoda lečenja (t=-0.603, p=0.547). Postoji statistička značajna razlika između grupe bolesnika koji su otpušteni ili prevedeni na drugu Kliniku i grupe pacijenata koji su umrli u odnosu na prosečan broj bolničkih dana (t=-3.211, p=0.002). Nije bilo statistički značajne razlike u dužini primene neinvazivne i invazivne mehaničke
ventilacije (t=-2.055, p=0.047).
Zaključak: Činjenica da su mnoge respiratorne bolesti hroničnog tipa, pre svega HOBP, bile otežano dijagnostikovane, kontrolisane i lečene u periodu tokom COVID-19 pandemije donosi nove izazove u radu respiratornih JIL i potrebno je dalje praćenje posledica koje će ova pandemija ostaviti.
Ključne reči: respiratorna jedinica intenzivnog lečenja, hronična opstruktivna bolest pluća, respiratorna insuficijencija, COVID-19 pandemija, neinvazivna ventilacija
LITERATURA
|
1. Akbaş T, Güneş H. Characteristics and outcomes of patients with chronic obstructive pulmonary disease PMid:36935534 PMCid:PMC10030250
|
| 2. Polistina GE, Di Somma C, Flora M, Maraolo AE, Carannante N, Langella G, et al. Respiratory Intensive Care Unit management and efficacy during the COVID-19 outbreak in Naples, Italy. Monaldi Arch Chest Dis 2022; 93: 2358. [CrossRef] PMid:36062992 |
| 3. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 72733. [CrossRef] PMid:31978945 PMCid:PMC7092803 |
| 4. Cote CG, Celli BR. Predictors of mortality in chronic obstructive pulmonary disease. Clin Chest Med 2007; 28: 515-24.[CrossRef] PMid:17720040 |
| 5. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med 2017; 195:557-82. [CrossRef] PMid:28128970 |
| 6. Ai-Ping C, Lee KH, Lim TK. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest 2005; 128:518-24. [CrossRef] PMid:16100133 |
| 7. Alaithan AM, Memon JI, Rehmani RS, et al. Chronic obstructive pulmonary disease: hospital and intensive care unit outcomes in the Kingdom of Saudi Arabia. Int J Chron Obstruct Pulmon Dis 2012; 7:819- 23.[CrossRef] PMid:23269866 PMCid:PMC3529632 |
| 8. Rivera-Fernandez R, Navarrete-Navarro P, Fernandez-Mondejar E, et al. Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med 2006; 34:2317- 24.[CrossRef] PMid:16849998 |
| 9. Weiss SM, Hudson LD. Outcome from respiratory failure. Crit Care Clin 1994; 10: 197-215. [CrossRef] |
| 10. Comellini V, Pacilli AM, Nava S. Benefits of non-invasive ventilation in acute hypercapnic respiratory failure. Respirology 2019; 24: 308-17.[CrossRef] PMid:30636373 |
| 11. Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000; 355: 1931-5. PMid:10859037 |
| 12. Salgado S, Oliveira AS, Nunes C, Oliveira F, Barbara C. Respiratory intermediate care unit (RICU) - What are we doing? Eur Respir J 2011; 38: 2083. |
| 13. Duan RR, Hao K, Yang T. Air pollution and chronic obstructive pulmonary disease. Chronic Dis Transl Med 2020; 6(4): 260-269. PMid:33336171 PMCid:PMC7729117 |
| 14. Anisoglou S, Asteriou C, Barbetakis N, Kakolyris S, Anastasiadou G, Pnevmatikos I. Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure. Hippokratia. 2013; 17(1): 60-3. |
| 15. Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018; 12: 1753465817750524. [CrossRef] PMid:29355081 PMCid:PMC5937157 |
| 16. Singh D, Mathioudakis AG, Higham A. Chronic obstructive pulmonary disease and COVID-19: interrelationships. Curr Opin Pulm Med. 2022; 28(2): 76-83. [CrossRef] PMid:34690257 PMCid:PMC8815646 |
| 17. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Algahtani AS, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One 2020; 15: e0233147. [CrossRef] PMid:32392262 PMCid:PMC7213702 |
| 18. Aveyard P, Gao M, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, et al. Association between preexisting respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med 2021; 9: 909-923. [CrossRef] PMid:33812494 |
1 Klinika za pulmologiju, Univerzitetski Klinički centar Niš